Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 30:13:943-962.
doi: 10.2147/DMSO.S232377. eCollection 2020.

Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications

Min Gong  1 , Song Wen  1 , Thiquynhnga Nguyen  1 , Chaoxun Wang  1 , Jianlan Jin  1 , Ligang Zhou  1
Affiliations
Review

Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications

Min Gong et al. Diabetes Metab Syndr Obes. .

Abstract

Background: Obesity and hyperuricemia mutually influence metabolic syndrome. This study discusses the metabolic relationships between obesity and hyperuricemia in terms of pathophysiology, complications, and treatments.

Methods: We searched for preclinical or clinical studies on the pathophysiology, complications, and therapy of obesity and hyperuricemia on the PubMed database.

Results: In this systemic review, we summarized our searching results on topics of pathophysiology, complications and therapeutic strategy. In pathophysiology, we firstly introduce genetic variations for obesity, hyperuricemia and their relationships by genetic studies. Secondly, we talk about the epigenetic influences on obesity and hyperuricemia. Thirdly, we describe the central metabolic regulation and the role of hyperuricemia. Then, we refer to the character of adipose tissue inflammation and oxidative stress in the obesity and hyperuricemia. In the last part of this topic, we reviewed the critical links of gut microbiota in the obesity and hyperuricemia. In the following part, we review the pathophysiology of major complications in obesity and hyperuricemia including insulin resistance and type 2 diabetes mellitus, chronic kidney disease, cardiovascular diseases, and cancers. Finally, we recapitulate the therapeutic strategies especially the novel pharmaceutic interventions for obesity and hyperuricemia, which concurrently show the mutual metabolic influences between two diseases.

Conclusion: The data reviewed here delineate the metabolic relationships between obesity and hyperuricemia, and provide a comprehensive overview of the therapeutic targets for the management of metabolic syndromes.

Keywords: complication; hyperuricemia; obesity; pathophysiology; pharmacotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
The comparison of pathophysiology of (A) obesity and (B) hyperuricemia. Abbreviations: GFR, glomerular filtration rate, NAFLD, non-alcoholic fatty liver disease.
See this image and copyright information in PMC

References

    1. Nicolaidis S. Environment and obesity. Metabolism. 2019;100:153942. doi: 10.1016/j.metabol.2019.07.006 - DOI - PubMed
    1. Gregory JW. Prevention of obesity and metabolic syndrome in children. Front Endocrinol (Lausanne). 2019;10:669. doi: 10.3389/fendo.2019.00669 - DOI - PMC - PubMed
    1. Hruby A, Manson JE, Qi L, et al. Determinants and consequences of obesity. Am J Public Health. 2016;106(9):1656–1662. doi: 10.2105/AJPH.2016.303326 - DOI - PMC - PubMed
    1. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–1396. doi: 10.1016/S0140-6736(16)30054-X - DOI - PMC - PubMed
    1. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–1932. doi: 10.1016/j.jacc.2008.12.068 - DOI - PubMed